COVID-19: characteristics and therapeutics
R Chilamakuri, S Agarwal - Cells, 2021 - mdpi.com
Novel coronavirus (COVID-19 or 2019-nCoV or SARS-CoV-2), which suddenly emerged in
December 2019 is still haunting the entire human race and has affected not only the …
December 2019 is still haunting the entire human race and has affected not only the …
Mesenchymal stem/stromal cell therapy for COVID-19 pneumonia: potential mechanisms, current clinical evidence, and future perspectives
W Yao, L Shi, Y Zhang, H Dong, Y Zhang - Stem Cell Research & Therapy, 2022 - Springer
Abstract The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), has spread into more than 200 countries …
respiratory syndrome coronavirus 2 (SARS-CoV-2), has spread into more than 200 countries …
Convalescent plasma therapy in patients with COVID-19
F Altuntas, N Ata, TN Yigenoglu, S Bascı, MS Dal… - … and Apheresis Science, 2021 - Elsevier
Introduction Passive antibody therapy has been used to immunize vulnerable people
against infectious agents. In this study, we aim to investigate the efficacy of convalescent …
against infectious agents. In this study, we aim to investigate the efficacy of convalescent …
Convalescent plasma and all-cause mortality of COVID-19 patients: systematic review and meta-analysis
N Mihalek, D Radovanović, O Barak, P Čolović… - Scientific Reports, 2023 - nature.com
Insight into the clinical potential of convalescent plasma in patients with coronavirus disease
(COVID-19) is important given the severe clinical courses in unvaccinated and seronegative …
(COVID-19) is important given the severe clinical courses in unvaccinated and seronegative …
Targeted therapy in Coronavirus disease 2019 (COVID-19): Implication from cell and gene therapy to immunotherapy and vaccine
M Shirzad, M Nourigorji, A Sajedi, M Ranjbar… - International …, 2022 - Elsevier
Severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) is a highly pathogenic and
transmissible virus. Infection caused by SARS-CoV-2 known as Coronavirus disease 2019 …
transmissible virus. Infection caused by SARS-CoV-2 known as Coronavirus disease 2019 …
[HTML][HTML] Convalescent plasma for the prevention and treatment of COVID-19: a systematic review and quantitative analysis
Background: The COVID-19 pandemic, caused by a novel coronavirus termed SARS-CoV-2,
has spread quickly worldwide. Convalescent plasma (CP) obtained from patients following …
has spread quickly worldwide. Convalescent plasma (CP) obtained from patients following …
[HTML][HTML] COVID-19 convalescent plasma as long-term therapy in immunodeficient patients?
Objectives The patients with hematological malignancies are a vulnerable group to COVID-
19, due to the immunodeficiency resulting from the underlying disease and oncological …
19, due to the immunodeficiency resulting from the underlying disease and oncological …
A novel nano therapeutic using convalescent plasma derived exosomal (CPExo) for COVID-19: A combined hyperactive immune modulation and diagnostics
Extracellular vesicles like exosomes are important therapeutic tactics for treating COVID-19.
By utilizing convalescent plasma derived exosomes (CP Exo) from COVID-19 recovered …
By utilizing convalescent plasma derived exosomes (CP Exo) from COVID-19 recovered …
Is there any potential management against COVID-19? A systematic review and meta-analysis
Purpose A recent survey has shown that the COVID-19 pandemic has culminated in
dramatical and critical treatment particularly in acute infected patients. In fact, this systematic …
dramatical and critical treatment particularly in acute infected patients. In fact, this systematic …
Structure-based screening of natural product libraries in search of potential antiviral drug-leads as first-line treatment to COVID-19 infection
The study focuses on identifying and screening natural products (NPs) based on their
structural similarities with chemical drugs followed by their possible use in first-line treatment …
structural similarities with chemical drugs followed by their possible use in first-line treatment …